Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Cetirizine → Cetirizine Fluticasone
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Cetirizine | HCID 2678 | — |
| 반응물 | Fluticasone | HCID 5311101 | — |
| 생성물 | Cetirizine Fluticasone | HCID 131730919 | — |
반응 단계
The purpose of this example was to evaluate the efficacy of cetirizine 0.1%/fluticasone 0.005% ophthalmic suspension compared to cetirizine 0.1% ophthalmic suspension, fluticasone 0.005% ophthalmic suspension and vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in a modified CAC model.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08569273B2 |
| 출처 데이터셋 | uspto-grants-2013_10 |
| ORD ID | ord-14ee4efaa114404cba65dbe412644580 |
| 출처 메모 | uspto-grants-2013_10 |